Skip to content

Symptoms observation via patient-reported outcomes for patients of locally advanced esophageal cancer accepted concurrent radiotherapy and chemotherapy

Symptoms observation via patient-reported outcomes for patients of locally advanced esophageal cancer accepted concurrent radiotherapy and chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049806
Enrollment
Unknown
Registered
2021-08-09
Start date
2021-08-15
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Case series:No

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. >=18 years old, regardless of gender; 2. Patients diagnosed as esophageal cancer by histopathology or cytology; 3. Locally advanced esophageal cancer patients who plan to receive concurrent radiotherapy and chemotherapy; 4. KPS score >=70 points; 5. Expected survival time >= 3 months; 6. Good compliance, voluntary consent and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Irreversible grade 3/4 adverse reactions caused by anti-tumor therapy; 2. Large pleural and ascites fluid and/or severe edema; 3. Patients have poor cognitive abilities, unable to answer questions, fill out questionnaires, or have mental disorders; 4. The researcher thinks it is not suitable to participate in this research.

Design outcomes

Primary

MeasureTime frame
weight;

Secondary

MeasureTime frame
Nutritional Risk Screening Score;Dysphagia score;Appetite score;Score of Brief Dietary Self-Assessment Scale;Quality of life score;Radiation Therapy Oncology Cooperative Group classification of radiation esophagitis;

Countries

China

Contacts

Public ContactWang Jun

The Fourth Hospital of Hebei Medical University

wangjunzr@163.com+86 13931182128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026